Endothelial Cell CD36 Reduces Atherosclerosis and Controls Systemic Metabolism
Authors:
Open Access
- 23 November 2021
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 8
Abstract
High-fat Western diets contribute to tissue dysregulation of fatty acid and glucose intake, resulting in obesity and insulin resistance and their sequelae, including atherosclerosis. New therapies are desperately needed to interrupt this epidemic. The significant idea driving this research is that the understudied regulation of fatty acid entry into tissues at the endothelial cell (EC) interface can provide novel therapeutic targets that will greatly modify health outcomes and advance health-related knowledge. Dysfunctional endothelium, defined as activated, pro-inflammatory, and pro-thrombotic, is critical in atherosclerosis initiation, in modulating thrombotic events that could result in myocardial infarction and stroke, and is a hallmark of insulin resistance. Dyslipidemia from high-fat diets overwhelmingly contributes to the development of dysfunctional endothelium. CD36 acts as a receptor for pathological ligands generated by high-fat diets and in fatty acid uptake, and therefore, it may additionally contribute to EC dysfunction. We created EC CD36 knockout (CD36°) mice using cre-lox technology and a cre-promoter that does not eliminate CD36 in hematopoietic cells (Tie2e cre). These mice were studied on different diets, and crossed to the low density lipoprotein receptor (LDLR) knockout for atherosclerosis assessment. Our data show that EC CD36° and EC CD36°/LDLR° mice have metabolic changes suggestive of an uncompensated role for EC CD36 in fatty acid uptake. The mice lacking expression of EC CD36 had increased glucose clearance compared with controls when fed with multiple diets. EC CD36° male mice showed increased carbohydrate utilization and decreased energy expenditure by indirect calorimetry. Female EC CD36°/LDLR° mice have reduced atherosclerosis. Taken together, these data support a significant role for EC CD36 in systemic metabolism and reveal sex-specific impact on atherosclerosis and energy substrate use.Keywords
Funding Information
- Heart and Stroke Foundation of Canada (GIA G-17-0019162)
This publication has 85 references indexed in Scilit:
- Oxidized LDL/CD36 interaction induces loss of cell polarity and inhibits macrophage locomotionMolecular Biology of the Cell, 2012
- Vav Family Rho Guanine Nucleotide Exchange Factors Regulate CD36-mediated Macrophage Foam Cell FormationJournal of Biological Chemistry, 2011
- A CD36-dependent pathway enhances macrophage and adipose tissue inflammation and impairs insulin signallingCardiovascular Research, 2010
- CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimerNature Immunology, 2009
- CD36, a Scavenger Receptor Involved in Immunity, Metabolism, Angiogenesis, and BehaviorScience Signaling, 2009
- Variants in the CD36 gene associate with the metabolic syndrome and high-density lipoprotein cholesterolHuman Molecular Genetics, 2008
- Platelet CD36 links hyperlipidemia, oxidant stress and a prothrombotic phenotypeNature Medicine, 2007
- Oxidized phosphatidylserine–CD36 interactions play an essential role in macrophage-dependent phagocytosis of apoptotic cellsJournal of Experimental Medicine, 2006
- A CD36-dependent signaling cascade is necessary for macrophage foam cell formationCell Metabolism, 2006
- CD36 is a sensor of diacylglyceridesNature, 2005